BACKGROUND: The effect of prearrest left ventricular ejection fraction (LVEF) on outcome after cardiac arrest is unknown. METHODS AND RESULTS: During a 26-month period, Utstein-style data were prospectively collected on 800 consecutive inpatient adult index cardiac arrests in an observational, single-center study at a tertiary cardiac care hospital. Prearrest echocardiograms were performed on 613 patients (77%) at 11+/-14 days before the cardiac arrest. Outcomes among patients with normal or nearly normal prearrest LVEF (> or = 45%) were compared with those of patients with moderate or severe dysfunction (LVEF < 45%) by chi(2) and logistic regression analyses. Survival to discharge was 19% in patients with normal or nearly normal LVEF compared with 8% in those with moderate or severe dysfunction (adjusted odds ratio, 4.8; 95% confidence interval, 2.3 to 9.9; P<0.001) but did not differ with regard to sustained return of spontaneous circulation (59% versus 56%; P=0.468) or 24-hour survival (39% versus 36%; P=0.550). Postarrest echocardiograms were performed on 84 patients within 72 hours after the index cardiac arrest; the LVEF decreased 25% in those with normal or nearly normal prearrest LVEF (60+/-9% to 45+/-14%; P<0.001) and decreased 26% in those with moderate or severe dysfunction (31+/-7% to 23+/-6%, P<0.001). For all patients, prearrest beta-blocker treatment was associated with higher survival to discharge (33% versus 8%; adjusted odds ratio, 3.9; 95% confidence interval, 1.8 to 8.2; P<0.001). CONCLUSIONS: Moderate and severe prearrest left ventricular systolic dysfunction was associated with substantially lower rates of survival to hospital discharge compared with normal or nearly normal function.
BACKGROUND: The effect of prearrest left ventricular ejection fraction (LVEF) on outcome after cardiac arrest is unknown. METHODS AND RESULTS: During a 26-month period, Utstein-style data were prospectively collected on 800 consecutive inpatient adult index cardiac arrests in an observational, single-center study at a tertiary cardiac care hospital. Prearrest echocardiograms were performed on 613 patients (77%) at 11+/-14 days before the cardiac arrest. Outcomes among patients with normal or nearly normal prearrest LVEF (> or = 45%) were compared with those of patients with moderate or severe dysfunction (LVEF < 45%) by chi(2) and logistic regression analyses. Survival to discharge was 19% in patients with normal or nearly normal LVEF compared with 8% in those with moderate or severe dysfunction (adjusted odds ratio, 4.8; 95% confidence interval, 2.3 to 9.9; P<0.001) but did not differ with regard to sustained return of spontaneous circulation (59% versus 56%; P=0.468) or 24-hour survival (39% versus 36%; P=0.550). Postarrest echocardiograms were performed on 84 patients within 72 hours after the index cardiac arrest; the LVEF decreased 25% in those with normal or nearly normal prearrest LVEF (60+/-9% to 45+/-14%; P<0.001) and decreased 26% in those with moderate or severe dysfunction (31+/-7% to 23+/-6%, P<0.001). For all patients, prearrest beta-blocker treatment was associated with higher survival to discharge (33% versus 8%; adjusted odds ratio, 3.9; 95% confidence interval, 1.8 to 8.2; P<0.001). CONCLUSIONS: Moderate and severe prearrest left ventricular systolic dysfunction was associated with substantially lower rates of survival to hospital discharge compared with normal or nearly normal function.
Authors: Vimal Ramjee; Anne V Grossestreuer; Yuan Yao; Sarah M Perman; Marion Leary; James N Kirkpatrick; Paul R Forfia; Daniel M Kolansky; Benjamin S Abella; David F Gaieski Journal: Resuscitation Date: 2015-08-28 Impact factor: 5.262
Authors: David G Beiser; Kimberly R Wojcik; Danhong Zhao; Gerasim A Orbelyan; Kimm J Hamann; Terry L Vanden Hoek Journal: Am J Physiol Heart Circ Physiol Date: 2010-04-02 Impact factor: 4.733
Authors: Jason Schultz; Nicolas Segal; James Kolbeck; Emily Caldwell; Marit Thorsgard; Scott McKnite; Tom P Aufderheide; Keith G Lurie; Demetris Yannopoulos Journal: Resuscitation Date: 2011-12 Impact factor: 5.262
Authors: Ryan W Morgan; Alexis A Topjian; Yan Wang; Natalie J Atkin; Todd J Kilbaugh; Francis X McGowan; Robert A Berg; Laura Mercer-Rosa; Robert M Sutton; Adam S Himebauch Journal: Pediatr Crit Care Med Date: 2020-04 Impact factor: 3.624
Authors: Cameron Dezfulian; Aleksey Alekseyenko; Kunjan R Dave; Ami P Raval; Rose Do; Francis Kim; Miguel A Perez-Pinzon Journal: Nitric Oxide Date: 2012-03-30 Impact factor: 4.427
Authors: David G Beiser; Gerasim A Orbelyan; Brendan T Inouye; James G Costakis; Kimm J Hamann; Elizabeth M McNally; Terry L Vanden Hoek Journal: Resuscitation Date: 2010-10-16 Impact factor: 5.262
Authors: Cameron Dezfulian; Sruti Shiva; Aleksey Alekseyenko; Akshay Pendyal; D G Beiser; Jeeva P Munasinghe; Stasia A Anderson; Christopher F Chesley; T L Vanden Hoek; Mark T Gladwin Journal: Circulation Date: 2009-08-24 Impact factor: 29.690
Authors: Yuan Yao; Nicholas James Johnson; Sarah Muirhead Perman; Vimal Ramjee; Anne Victoria Grossestreuer; David Foster Gaieski Journal: Intern Emerg Med Date: 2017-10-05 Impact factor: 3.397